Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $79.0200 (1.7%) ($77.7700 - $79.5700) on Wed. Nov. 10, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.31% (three month average) | RSI | 40 | Latest Price | $79.0200(1.7%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX declines -0.3% a day on average for past five trading days. | Weekly Trend | BAX declines -2.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(37%) SPLV(35%) VYM(35%) SDY(34%) XLP(34%) | Factors Impacting BAX price | BAX will decline at least -0.655% in a week (0% probabilities). VIXM(-21%) UUP(-20%) VXX(-2%) TLT(-2%) EDOC(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.655% (StdDev 1.31%) | Hourly BBV | 1 () | Intraday Trend | 1.6% | | | |
|
Resistance Level | $79.81 | 5 Day Moving Average | $78.36(0.84%) | 10 Day Moving Average | $78.93(0.11%) | 20 Day Moving Average | $79.81(-0.99%) | To recent high | -5.5% | To recent low | 7.1% | Market Cap | $40.315b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |